At a glance
ClinicalIndex Comparison RecordN/ACompleted· 68 enrolled
Drug / intervention
ChatGPTother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Al to Improve the Diagnosis of Rare Rheumatic Diseases
In Brief
A clinical study evaluating ChatGPT for Rheumatic Diseases. Completed, enrolled 68 participants across 1 site.
Detailed Summary
This trial aims to assess the impact of providing medical students with access to ChatGPT, a state-of-the-art large language model, in comparison to conventional diagnostic decision support tools, on their diagnostic accuracy for rare rheumatic diseases.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatic Diseases
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20252026
First PostedDec 2024
Enrollment StartJan 2025
Primary CompletionMar 2025
TodayJul 2026
First PostedDec 27, 2024
Enrollment StartJan 7, 2025
Primary CompletionMar 30, 2025
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 1.5 years ago
Interventions
ChatGPTother
OpenAI's ChatGPT language model with chat interface.